Gent, Belgium, June 12, 2023

Aphea.Bio is proud to announce that the company's first commercial product, the innovative biostimulant ΛCTIV by Aphea.Bio® is being launched in Poland! To mark this milestone, Syngenta Polska hosted an exclusive launch event on the 5th of June 2023 to introduce the new biostimulant to a diverse range of stakeholders including industry experts, farmers, and key influencers.

During the event, representatives from Syngenta Polska highlighted the ground-breaking potential of ΛCTIV by Aphea.Bio®, which offers Polish farmers a sustainable and economically viable solution to boost wheat yield and minimise the use of traditional fertilisers.

Regulatory approvals are currently being finalised and the first deliveries of ΛCTIV by Aphea.Bio® are scheduled for August/September 2023, nicely in time for this year's winter wheat season. Market introductions in additional countries are currently in preparation for 2024, further broadening the availability of innovative & sustainable solutions to farmers in Europe.

Isabel Vercauteren, CEO, and co-founder of Aphea.Bio: "By putting ΛCTIV by Aphea.Bio® in the hands of Polish farmers, we are proud to see our ambition to create a more profitable and sustainable future for European growers become reality. This milestone signifies the tangible progress we have made in bringing transformative impact to European agriculture in partnership with Syngenta Crop Protection. We are excited for what's on the horizon"

ΛCTIV by Aphea.Bio® is a biostimulant applied as a seed treatment on wheat. Based on beneficial micro-organisms, the biostimulant improves nutrient uptake of crops and increases yields by as much as five percent, even with reduced fertiliser use.

The official launch of ΛCTIV by Aphea.Bio® into the European market shows a significant leap in the shared journey of Aphea.Bio and Syngenta Crop Protection to bring powerful seed treatments to European farmers that will enhance the sustainability, reliability, and profitability of their farming operations.

About Aphea.Bio

Aphea.Bio is a fully integrated microbial product development company dedicated to food security and ensuring a safe and healthy food chain and is providing novel, science-based solutions to build the agriculture of the future: sustainable, reliable, and profitable. Located in Gent, Belgium, we have a highly dedicated and qualified team of scientist and industry experts. Based on our unique high throughput APEX® R&D platform utilising the untapped microbial space, we have been able to build a broad biostimulant and biocontrol pipeline based on naturally occurring micro-organisms.

We believe that with a fresh and sincere spirit of innovation, result-driven science, and the courage to go off the beaten track, there is fertile ground to develop efficacious biological solutions to help complement or partially replace products in the major chemical indications.

To learn more, visit www.aphea.bio or follow us on LinkedIn at www.linkedin.com/company/aphea-bio.

Aphea Bio
Charlotte Klank
Head of Regulatory Affairs | Communications
[email protected]


Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ("legitimate interest"). However, if you do not wish to receive further information about Aphea.Bio, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement.

Cautionary Statement Regarding Forward-Looking Statements

This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Aphea.Bio, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Aphea.Bio assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

© Aphea.Bio, Technologiepark Zwijnaarde 21, 9052 Zwijnaarde.